Inyx to Present at Rodman & Renshaw Healthcare Conference

Inyx to Present at Rodman & Renshaw Healthcare Conference 


NEW YORK, May 2  /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN
BOARD: IYXI) , a specialty pharmaceutical company with a focus on niche drug
delivery technologies and products, will be presenting at the Rodman & Renshaw
Techvest Annual Global Healthcare Conference in Paris, France.

Inyx's presentation will be this Thursday, May 5, at 4:35 p.m. Paris time,
which is 10:35 a.m. Eastern Daylight Time in the United States.

A webcast of the Inyx presentation will be available both live and on a
recorded basis for 90 days afterwards at:
http://www.wsw.com/webcast/rrshq5/iyxi.ob.  The webcast link can also be
accessed from the Investor Relations/Investor Presentation section at Inyx's
website: http://www.inyxinc.com/.

The presentation will feature an overview of Inyx's business niches and
corporate goals, including Inyx's just completed acquisition of the assets and
certain business of Aventis Pharmaceuticals Puerto Rico from Aventis
Pharmaceuticals, Inc., a wholly owned subsidiary of sanofi-aventis Group
(NYSE:SNY).  Inyx will also discuss other new business and strategic
relationships the Company is gaining as well as Inyx's own initial proprietary
products that are expected to be ready for commercial marketing by the end of
2005.

About Inyx

Inyx, Inc. is a specialty pharmaceutical company with aerosol drug delivery
technologies and products for the treatment of respiratory, allergy,
dermatological, topical and cardiovascular conditions.  Inyx focuses its
expertise on both prescription and over-the-counter pharmaceutical products,
and provides specialty pharmaceutical development and production consulting
services to the international healthcare market.  In addition, Inyx is
developing its own proprietary products to be marketed by selected clients and
strategic partners, which include some of the largest pharmaceutical companies.
 The company's operations are conducted through several wholly owned
subsidiaries: Inyx USA, Ltd., which has newly acquired operations in Manati,
Puerto Rico; Inyx Pharma Limited, which has development and production
facilities located near Manchester, England; and Inyx Canada, Inc. based in
Toronto, which provides business development and support services.  Inyx,
Inc.'s corporate offices are in New York City.  For more information, please
visit: http://www.inyxinc.com/.

Safe Harbor

Statements about the Company's future expectations, including future revenues
and earnings, and all other statements in this press release other than
historical facts, are "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995.  The Company intends that such forward-looking
statements be subject to the safe harbors created thereby.  Since these
statements involve risks and uncertainties and are subject to change at any
time, the Company's actual results could differ materially from expected
results.

  For more information, please contact:
   Jay M. Green, Executive VP
   Inyx, Inc.
   

DATASOURCE: Inyx, Inc.



CONTACT:  Jay M. Green, Executive VP of Inyx, Inc., 



Web site:  http://www.inyxinc.com/

Copyright